July 3, 2018
Most flu vaccines are produced using eggs, a method known to contribute to high failure rates. A new version grown in canine kidney cells was expected to produce measurably better results, but the data just in paints a very different picture: the “new-and-improved” cell-based flu vaccine offers little, if any, benefit over the conventional version.